Adhesion-linked kinases in cancer; emphasis on Src, focal adhesion kinase and PI 3-kinase

European Journal of Cancer

Volumn 36, Issue 13, 2000, Pages 1595-1606

  Jones, R J ^a   Brunton, V G ^a   Frame, M C ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Adhesion; Cell signalling; Focal adhesion kinase (FAK); Phosphatidylinositol 3 kinase (PI 3 kinase); Src

Indexed keywords

FOCAL ADHESION KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE;

CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL COMMUNICATION; CELL GROWTH; CELL INVASION; CELL SURVIVAL; ENZYME REGULATION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL ADHESION; CELL COMMUNICATION; CELL DIVISION; CELL MOVEMENT; CELL SURVIVAL; CYTOSKELETON; EXTRACELLULAR MATRIX; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-TYROSINE KINASES; PTEN PHOSPHOHYDROLASE; SRC-FAMILY KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 0033852788     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00153-2     Document Type: Article

References (127)

1. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumour cells. J. Exp. Med. 13:1911;397-411.
2. Stehelin D., Varmus H.E., Bishop J.M., Vogt P.K. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature. 260:1976;170-173.
3. Kaplan K.B., Swedlow J.R., Varmus H.E., Morgan D.O. Association of p60c-src with endosomal membranes in mammalian fibroblasts. J. Cell. Biol. 118:1992;321-333.
4. Fincham V.J., Unlu M., Brunton V.G., Pitts J.D., Wyke J.A., Frame M.C. Translocation of Src kinase to the cell periphery is mediated by the actin cytoskeleton under the control of the Rho family of small G proteins. J. Cell. Biol. 135:1996;1551-1564.
5. Cooper J.A., MacAuley A. Potential positive and negative autoregulation of pp60src by intermolecular autoregulation. Proc. Natl. Acad. Sci. USA. 85:1988;4232-4236.
6. Haefner B., Baxter R., Fincham V.J., Downes C.P., Frame M.C. Cooperation of src homology domains in the regulated binding of phosphatidylinositol-3-kinase- a role for the src homology-2 domain. J. Biol. Chem. 270:1995;7937-7943.
7. Takeya T., Hanafusa H. Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell. 32:1983;881-890.
8. Okada M., Nakagawa H. A protein tyrosine kinase involved in regulation for pp60c-src function. J. Biol. Chem. 264:1989;20886-20893.
9. Gould K., Hunter T. Platelet-derived growth factor induces multisite phosphorylation of pp60c-src and increases its protein-tyrosine kinase activity. Mol. Cell. Biol. 8:1988;3345-3356.
10. Kypta R.M., Goldberg Y., Ulug E.T., Courtneidge S.A. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell. 62:1990;481-492.
11. Klinghoffer R.A., Sachsenmaier C., Cooper J.A., Soriano P. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:1999;2459-2471.
12. Kaplan K.B., Swedlow J.R., Morgan D.O., Varmus H.E. c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. Genes Dev. 9:1995;1505-1517.
13. Fincham V.J., Frame M.C. The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J. 17:1998;81-92.
14. Owens D.W., McLean G.W., Wyke A.W.et al. The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol. Biol. Cell. 11:2000;51-64.
15. Boyer B., Roche S., Denoyelle M., Thiery J.P. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J. 16:1997;5904-5913.
16. Catling A.D., Wyke J.A., Frame M.C. Mitogenesis of quiescent chick fibroblasts by v-src-dependence on events at the membrane leading to early changes in AP-1. Oncogene. 8:1993;1875-1886.
17. Roche S., Koegl M., Barone M.V., Roussel M.F., Courtneidge S.A. DNA synthesis induced by some but not all growth factors requires src family protein tyrosine kinases. Mol. Cell. Biol. 15:1995;1102-1109.
18. Jove R., Hanafusa H. Cell transformation by the viral src oncogene. Ann. Rev. Cell. Biol. 3:1987;31-56.
19. Welham M.J., Wyke J.A., Lang A., Wyke A.W. Mitogenesis induced by pp60v-src is not accompanied by increased expression of immediate early response genes. Oncogene. 5:1990;161-169.
20. Taylor S.J., Shalloway D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature. 368:1994;867-871.
21. Fumagalli S., Totty N.F., Hsuan J.J., Courtneidge S.A. A target for src in mitosis. Nature. 368:1994;871-874.
22. Verbeek B.S., Vroom T.M., Rijksen G. Overexpression of c-Src enhances cell-matrix adhesion and cell migration in PDGF-stimulated NIH3T3 fibroblasts. Exp. Cell. Res. 248:1999;531-537.
23. Empereur S., Djellou S., Di Giola Y.et al. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes. cooperation between src and HGF/Met in invasion Br. J. Cancer. 75:1997;241-250.
24. Pories S.E., Hess D.T., Swenson K.et al. Overexpression of pp60c-src elicits invasive behavior in rat colon epithelial cells. Gastroenterology. 114:1998;1287-1295.
25. Brunton V.G., Ozanne B.W., Paraskeva C., Frame M.C. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene. 14:1997;283-293.
26. Hamaguchi M., Yamagata S., Thant A.A.et al. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src. Oncogene. 10:1995;1037-1043.
27. Mukhopadhyay D., Tsiokas L., Zhou X.-M., Foster D., Brugge J.S., Sukhatme V.P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 375:1995;577-581.
28. Johnson D, Agochiya M, Samejima K, Earnshaw W, Frame M, Wyke J. Regulation of both apoptosis and cell survival by the v-Src oncoprotein. Cell Death Different 2000, in press.
29. Wong B.R., Besser D., Kim N.et al. TRANCE, a TNF family complex involving TRAF6 and c-Src. Mol. Cell. 4:1999;1041-1049.
30. Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell. 100:2000;293-296.
31. Staley C.A., Parikh N.U., Gallick G.E. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-src. Cell. Growth Different. 8:1997;269-274.
32. Wiener J.R., Nakano K., Kruzelock R.P., Bucana C.D., Bast R.C., Gallick G.E. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Clin. Cancer Res. 5:1999;2164-2170.
33. Irby R., Mao W., Coppola D.et al. Overexpression of normal c-src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential. Cell. Growth Different. 8:1997;1287-1295.
34. Mao W., Irby R., Coppola D.et al. Activation of c-src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene. 15:1997;3083-3090.
35. Tatsuka M., Ota T., Yamagishi N.et al. Different metastatic potentials of ras and src-transformed BALB/c 3T3 A31 variant cells. Mol. Carcinogenesis. 15:1996;300-308.
36. Irby R., Mao W., Coppola D.et al. Activating SRC mutation in a subset of advanced human colon cancers. Nature Genet. 21:1999;187-190.
37. Daigo Y., Furukawa Y., Kawasoe T.et al. Absence of genetic alteration at codon 531 of the human c-src gene in 479 advanced colorectal cancers from Japanese and Caucasian patients. Cancer Res. 59:1999;4222-4224.
38. Verbeek B.S., Vroom T.M., Adriaansen-Slot S.S.et al. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J. Pathol. 180:1996;383-388.
39. van Oijen M.G.C.T., Rijksen G., ten Broek F.W., Slootweg P.J. Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. J. Oral. Path. Med. 27:1998;152.
40. Lutz M.P., Silke Esser I.B., Flossman-Kast B.B.M.et al. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem. Biophys. Res. Commun. 243:1998;503-508.
41. Cartwright C., Meisler A., Eckhart W. Activation of the pp60src protein kinase is an early event in colonic carcinogenesis. Proc. Natl. Acad. Sci. USA. 87:1990;558-562.
42. Cartwright C., Coad C., Egbert B. Elevated c-src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J. Clin. Invest. 93:1994;509-515.
43. Talamonti M.S., Roh M.S., Curley S.A., Gallick G.E. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. Clin. Invest. 91:1993;53-60.
44. Egan C., Pang A., Durda D., Cheng H.-C., Wang J.H., Fujita D.J. Activation of Src in human breast tumor cell lines. elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530 Oncogene. 18:1999;1227-1237.
45. Schaller M.D., Borgman C.A., Cobb B.S., Vines R.R., Reynolds A.B., Parsons J.T. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA. 89:1992;5192-5196.
46. Hanks S.K., Calalb M.B., Harper M.C., Patel S.K. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. USA. 89:1992;8487-8491.
47. Kornberg L., Earp H.S., Parsons J.T., Schaller M., Juliano R.L. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. 267:1992;23439-23442.
48. Devor B.B., Zhang X., Patel S.K., Polte T.R., Hanks S.K. Chicken and mouse focal adhesion kinases are similar in structure at their amino termini. Biochem. Biophys. Res. Commun. 190:1993;1084-1089.
49. Andre E., Becker-Andre M. Expression of an N-terminally truncated form of human focal adhesion kinase in brain. Biochem. Biophys. Res. Commun. 190:1993;140-147.
50. Schaller M.D., Otey C.A., Hildebrand J.D., Parsons J.T. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J. Cell. Biol. 130:1995;1181-1187.
51. Hildebrand J.D., Taylor J.M., Parsons J.T. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol. Cell. Biol. 16:1996;3169-3178.
52. Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell. Biol. 140:1998;211-221.
53. Hildebrand J.D., Schaller M.D., Parsons J.T. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J. Cell. Biol. 123:1993;993-1005.
54. Tachibana K., Sato T., D'Avirro N., Morimoto C. Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J. Exp. Med. 182:1995;1089-1099.
55. Richardson A., Parsons T. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK [published erratum appears in Nature 1996 Jun 27;381(6585):810]. Nature. 380:1996;538-540.
56. Burridge K., Turner C.E., Romer L.H. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix. a role in cytoskeletal assembly J. Cell. Biol. 119:1992;893-903.
57. Guan J.L., Shalloway D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature. 358:1992;690-692.
58. Schaller M.D., Hildebrand J.D., Shannon J.D., Fox J.W., Vines R.R., Parsons J.T. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14:1994;1680-1688.
59. Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:1994;786-791.
60. Calalb M.B., Polte T.R., Hanks S.K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity. a role for Src family kinases Mol. Cell. Biol. 15:1995;954-963.
61. Calalb M.B., Zhang X., Polte T.R., Hanks S.K. Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. Biochem. Biophys. Res. Commun. 228:1996;662-668.
62. McLean GW, Fincham VJ, Frame MC. v-Src induces tyrosine phosphorylation of focal adhesion kinase independently of tyrosine 397 and formation of a complex with Src. J Biol Chem, in press.
63. Chen H.C., Guan J.L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA. 91:1994;10148-10152.
64. MacAuley A., Cooper J.A. Structural differences between repressed and derepressed forms of p60c-src. Mol. Cell. Biol. 9:1989;2648-2656.
65. - cell migration. EMBO J. 17:1998;5933-5947.
66. Renshaw M.W., Price L.S., Schwartz M.A. Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J. Cell. Biol. 147:1999;611-618.
67. Lin T.H., Aplin A.E., Shen Y.et al. Integrin-mediated activation of MAP kinase is independent of FAK. evidence for dual integrin signaling pathways in fibroblasts J. Cell. Biol. 136:1997;1385-1395.
68. Zachary I., Rozengurt E. Focal adhesion kinase (p125FAK). a point of convergence in the action of neuropeptides, integrins, and oncogenes Cell. 71:1992;891-894.
69. Richardson A., Malik R.K., Hildebrand J.D., Parsons J.T. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK. a role for paxillin tyrosine phosphorylation Mol. Cell. Biol. 17:1997;6906-6914.
70. Fincham V.J., Wyke J.A., Frame M.C. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts [published erratum appears in Oncogene 1995 Nov 16;11(10):2185]. Oncogene. 10:1995;2247-2252.
71. Ilic D., Furuta Y., Kanazawa S.et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 377:1995;539-544.
72. Gilmore A.P., Romer L.H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell. 7:1996;1209-1224.
73. Sieg D.J., Hauck C.R., Schlaepfer D.D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell. Sci. 112:1999;2677-2691.
74. Gates R.E., King L.E. Jr., Hanks S.K., Nanney L.B. Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell. Growth Different. 5:1994;891-899.
75. Hungerford J.E., Compton M.T., Matter M.L., Hoffstrom B.G., Otey C.A. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J. Cell. Biol. 135:1996;1383-1390.
76. Frisch S.M., Vuori K., Ruoslahti E., Chan-Hui P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell. Biol. 134:1996;793-799.
77. Xu L.H., Owens L.V., Sturge G.C.et al. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell. Growth Different. 7:1996;413-418.
78. Xu L.H., Yang X., Craven R.J., Cance W.G. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell. Growth Different. 9:1998;999-1005.
79. Crouch D.H., Fincham V.J., Frame M.C. Targeted proteolysis of the focal adhesion kinase pp125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. Oncogene. 12:1996;2689-2696.
80. Wen L.P., Fahrni J.A., Troie S., Guan J.L., Orth K., Rosen G.D. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272:1997;26056-26061.
81. Shibata K., Kikkawa F., Nawa A.et al. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. 58:1998;900-903.
82. Akasaka T., van Leeuwen R.L., Yoshinaga I.G., Mihm M.C. Jr., Byers H.R. Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J. Invest. Dermatol. 105:1995;104-108.
83. Weiner T.M., Liu E.T., Craven R.J., Cance W.G. Expression of focal adhesion kinase gene and invasive cancer. Lancet. 342:1993;1024-1025.
84. McCormack S.J., Brazinski S.E., Moore J.L. Jr., Werness B.A., Goldstein D.J. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene. 15:1997;265-274.
85. Tremblay L., Hauck W., Aprikian A.G., Begin L.R., Chapdelaine A., Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int. J. Cancer. 68:1996;164-171.
86. Owens L.V., Xu L., Craven R.J.et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55:1995;2752-2755.
87. Judson P.L., He X., Cance W.G., Van Le L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer. 86:1999;1551-1556.
88. Han N.M., Fleming R.Y., Curley S.A., Gallick G.E. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases. independence from c-src or c-yes activation Ann. Surg. Oncol. 4:1997;264-268.
89. Agochiya M., Brunton V.G., Owens D.W.et al. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene. 18:1999;5646-5653.
90. Withers B.E., Hanks S.K., Fry D.W. Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and non transformed cells. Cancer Biochem. Biophys. 15:1996;127-139.
91. Carpenter C.L., Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell. Biol. 8:1996;153-158.
92. Cantley L.C., Auger K.R., Carpenter C.et al. Oncogenes and signal transduction. Cell. 65:1991;281-302.
93. Chang H.W., Aoki M., Fruman D.et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science. 276:1997;1848-1850.
94. Gillham H., Golding M.C.H.M., Pepperkok R., Gullick W.J. Intracellular movement of green fluorescent protein-tagged phosphatidylinositol 3-kinase in response to growth factor receptor signalling. J. Cell. Biol. 146:1999;869-880.
95. Machesky L.M., Hall A. Rho. a connection between membrane receptor signalling and the cytoskeleton Trends Cell. Biol. 6:1996;304-310.
96. Rodriguez-Viciana P., Warne P.H., Khwaja A.et al. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:1997;457-467.
97. Keely P.J., Westwick J.K., Whitehead I.P., Der C.J., Parise L.V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature. 390:1997;632-636.
98. Shaw L.M., Rabinovitz I., Wang H.H.-F., Toker A., Mercurio A.M. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell. 91:1997;949-960.
99. Han J., Luby-Phelps K., Das B.et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 279:1998;558-560.
100. Khwaja A., Rodriguez-Viciana P., Wennstrom S., Warne P.H., Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:1997;2783-2793.
101. Datta S.R., Brunet A., Greenberg M.E. Cellular survival. a play in three Akts Genes Dev. 13:1999;2905-2927.
102. Andjelkovic M., Alessi D.R., Meier R.et al. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272:1997;31515-31524.
103. Franke T.F., Kaplan D.R., Cantley L.C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 275:1997;665-668.
104. Alessi D.R., James S.R., Downes C.P.et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα Curr. Biol. 7:1997;261-269.
105. Stokoe D., Stephens L.R., Copeland T., Gaffney P.R.J., Reese C.B., Painter G.F. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 277:1997;567-570.
106. Li J., Yen C., Liaw D.et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
107. Li D., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β Cancer Res. 57:1997;2124-2129.
108. Steck P.A., Pershouse M.A., Jasser S.A.et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15:1997;356-362.
109. Ali I.U., Schriml L.M., Dean M. Mutational spectra of PTEN/MMAC1 gene. a tumor suppressor with lipid phosphatase activity J. Natl. Cancer Inst. 91:1999;1922-1932.
110. Myers M.P., Stolarov J.P., Eng C.et al. P-TEN, the tumour suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA. 94:1997;9052-9057.
111. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:1998;13375-13378.
112. Myers M.P., Pass I., Batty I.H.et al. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA. 95:1998;13513-13518.
113. Furnari F.B., Lin H., Huang H.J.S., Cavenee W.K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA. 94:1997;12479-12484.
114. 1 growth arrest in glioma cells. Cancer Res. 58:1998;5002-5008.
115. 1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. USA. 95:1998;15406-15411.
116. Philips W.A., St Clair F., Munday A.D., Thomas R.J.S., Mitchell C.A. Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors. Cancer. 83:1998;41-47.
117. Haas-Kogan D., Shalev N., Wong M., Mills G., Yount G., Stokoe D. Protein kinase B(PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol. 8:1998;1195-1198.
118. Stambolic V., Suzuki A., Lois de la Pompa J.et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:1998;29-39.
119. 1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA. 96:1999;2110-2115.
120. Wu X., Senechal K., Neshat M.S., Whang Y.E., Sawyers C.L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA. 95:1998;15587-15591.
121. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:1998;3499-3511.
122. Cheng J.Q., Godwin A.K., Bellacosa A.et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA. 89:1992;9267-9271.
123. Cheng J.Q., Ruggeri B., Klein W.M.et al. Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA. 93:1996;3636-3641.
124. Bellacosa A., Testa J.R., Staal S.P., Tsichlis P.N. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 254:1991;274-277.
125. Cas Cancer Res. 59:1999;442-449.
126. Sun H., Lesche R., Li D.et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA. 96:1999;6199-6204.
127. Maier D., Jones G., Li X.et al. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res. 59:1999;5479-5482.